SOCS3 is an endogenous inhibitor of pathologic angiogenesis

TNFα and SOCS3 regulate IRS-1 to increase retinal endothelial cell apoptosis

(2012) Youde Jiang et al.   CELLULAR SIGNALLING

Vascular endothelial growth factors and receptors: Anti-angiogenic therapy in the treatment of cancer

(2011) Sònia Tugues et al.   MOLECULAR ASPECTS OF MEDICINE

5-Lipoxygenase Metabolite 4-HDHA Is a Mediator of the Antiangiogenic Effect of  -3 Polyunsaturated Fatty Acids

(2011) P. Sapieha et al.   Science Translational Medicine

Postnatal Weight Gain Modifies Severity and Functional Outcome of Oxygen-Induced Proliferative Retinopathy

(2010) Andreas Stahl et al.   AMERICAN JOURNAL OF PATHOLOGY

Short Communication: PPARγ Mediates a Direct Antiangiogenic Effect of ω3-PUFAs in Proliferative Retinopathy

(2010) Andreas Stahl et al.   CIRCULATION RESEARCH

Loss of SOCS3 expression is associated with an increased risk of recurrent disease in breast carcinoma

(2010) Mingzhen Ying et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Conversion of vascular endothelial cells into multipotent stem-like cells

(2010) Damian Medici et al.   NATURE MEDICINE

Computer-aided quantification of retinal neovascularization

(2009) A. Stahl et al.   ANGIOGENESIS